The introduction of new vaccines into developing countries
- 1 February 1999
- journal article
- review article
- Published by Elsevier BV in Vaccine
- Vol. 17 (7-8), 646-652
- https://doi.org/10.1016/s0264-410x(98)00246-1
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Prospects for the use of new vaccines in developing countries: cost is not the only impedimentVaccine, 1996
- Evaluating New Vaccines for Developing CountriesJAMA, 1996
- Lombok Hepatitis B Model Immunization Project: Toward Universal Infant Hepatitis B Immunization in IndonesiaThe Journal of Infectious Diseases, 1995
- The crisis in vaccine supply: a framework for actionVaccine, 1994
- Global Control of Hepatitis B Through Vaccination: Role of Hepatitis B Vaccine in the Expanded Programme on ImmunizationClinical Infectious Diseases, 1989
- Recombinant versus plasma-derived hepatitis B vaccines: issues of safety, immunogenicity and cost-effectivenessVaccine, 1988
- COST-BENEFIT ANALYSIS OF HEPATITIS-B VACCINATIONThe Lancet, 1987
- The cost-effectiveness of hepatitis B vaccineJournal of Infection, 1983
- Should homosexuals be vaccinated against hepatitis B virus? Cost and benefit assessment.BMJ, 1983
- HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS: A Prospective Study of 22 707 Men in TaiwanThe Lancet, 1981